Tracking 0LB2? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Supernus Pharmaceuticals, Inc. (0LB2) short interest & options flow

LSE

$39.43+3.38% 1d-8.13% 1w-5.92% 1mClose: 19 Oct 2026

Cost to borrow: Low
Availability: High

Market cap: $2.31B
Next earnings: 29 Oct 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 20 Oct 2026

0LB2 news and analysis

RSS

No long-form analysis yet for 0LB2. Pulse alerts and the live data picture are available on ORTEX.

Open 0LB2 on ORTEX →

Want the live picture for 0LB2?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for 0LB2 — free to start on ORTEX.